Articles Tagged With:
-
The Best Use of Statins in Patients with Coronary Artery Disease
A randomized, multicenter study of high-intensity statin therapy to a treat-to-target approach in coronary artery disease patients showed no difference in three-year outcomes. These results suggest treating to a target may be more suitable to individual patients compared to blanket high-intensity statin use.
-
Cardiovascular Outcomes with Bempedoic Acid, a New Statin Alternative
A trial of bempedoic acid vs. placebo for statin-intolerant patients showed bempedoic acid significantly lowered LDL cholesterol levels and prevented more major adverse cardiovascular events after a median follow-up of 41 months. Although nonserious side effects were numerically higher for those on bempedoic acid, serious adverse events were not significantly different from placebo.
-
An Oral PCSK9 Inhibitor — Coming Soon?
A Phase IIb study of four doses of MK-0616, an orally administered PCSK9 inhibitor, compared to placebo showed significant reductions in LDL cholesterol levels without any differences in adverse effects over eight weeks.
-
Poor Sleep Patterns Could Raise Stroke Risk
Researchers provide another reason why patients should be resting well every night.
-
Surgeon Prevails When Patient’s Expert Cannot Tie Injury to Allegedly Negligent Surgery
The failure to admit medical records was a big problem for the plaintiff’s case, as was the expert’s failure to directly address how the mesh plug caused the patient’s pain. In defending these kinds of cases, it is important for defendants and their counsel to force the plaintiff to honor the rules of evidence to admit their exhibits and to prove causation, whether through expert testimony or otherwise.
-
Deadline Bars Medical Malpractice Claims and Wrongful Death Claims
On the substantive medical side, the obvious negligence inflicted on the patient by both a healthcare facility and physicians must be addressed first. This case also illustrates the legal interplay between three timing rules and is a strong example of how a state’s application of those rules can drastically affect a case.
-
Pediatric Mental Health Crisis Is ECRI’s Top Safety Concern for 2023
The pediatric mental health crisis is No. 1 on ECRI’s top 10 patient safety concerns for 2023.
-
CMS Changes Protocols for Stark Law Self-Disclosures
CMS recently announced updates to its voluntary self-referral disclosure protocol, including changes made to streamline submissions. The revised process makes three key changes to reduce burdens on self-disclosing providers.
-
DOJ Withdraws Support for Antitrust Safety Zones in Healthcare
The Department of Justice’s Antitrust Division recently withdrew its support from three joint statements with the Federal Trade Commission that created antitrust safety zones for the healthcare industry. Risk managers should consider how this change affects their employer’s exposure to antitrust charges. -
Fake Diplomas Pose Risk to Healthcare Employers
Employees with falsified credentials can pose a serious threat to patient safety and expose healthcare employers to great liability. Civil and regulatory consequences can occur.